Obesity Featured Articles

  1. Solving Trial Enrollment Challenges With Direct-To-Patient Recruitment 1/6/2026

    Overcome enrollment bottlenecks by shifting from site-centric models to tech-enabled, direct-to-patient outreach.

  2. How Rescue Studies Use Direct-To-Patient Strategies To Accelerate Clinical Trial Enrollment 1/6/2026

    If your trial struggles to overcome enrollment bottlenecks, a tech-enabled rescue strategy could be the solution.

  3. Why We Need To Look To The Future Of Clinical Trials 1/6/2026

    Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.

  4. How DCTs Can Shift The Pediatric Rare Disease Research Landscape 1/6/2026

    DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.

  5. Psychiatric Drug Development Renaissance: With Familiar Risks 1/6/2026

    Emerging psychiatric therapies bring hope, but progress is fragile. Biomarker-driven, mechanism-first approaches help overcome biological, regulatory, and commercial barriers.

  6. Trailblazing Clinical Drug Development In Dermatology 1/6/2026

    AI, imaging, and biomarkers are transforming trials, reducing subjectivity and improving sensitivity while enabling decentralized designs, faster timelines, and more precise insights.

  7. Clinical Research Trends And IRB Expectations For 2026 1/6/2026

    Oversight in 2026 requires adaptability as AI, consent standards, and regulatory uncertainty challenge sponsors and IRBs to balance ethics with innovation through proactive planning and collaboration.

  8. Medical Insight's Role In Early-Phase Clinical Development 1/6/2026

    Medical insight reduces risk, strengthens protocols, and accelerates timelines — enhancing safety, feasibility, and collaboration for successful trials and reliable outcomes.

  9. Why Early Medical Assessment Matters In Clinical Trials 1/6/2026

    Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.

  10. 2026: From Experimentation To Operational Reality In Clinical Research 1/6/2026

    Velocity Clinical Research COO Nick Spittal shares several trends he sees shaping up for 2026.